Ranibizumab or Bevacizumab in Patients With Neovascular AMDRanibizumab or Bevacizumab in Patients With Neovascular AMD
Is there a particular anti-VEGF agent that works best in neovascular AMD? This new study compares ranibizumab and bevacizumab. The British Journal of Ophthalmology
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Ophthalmology Journal Article Source Type: news